The Medicare for All Act (S.1506) establishes a federal, entitlement health insurance program that makes every U.S. resident eligible for a comprehensive benefit package and generally prohibits patient cost‑sharing. Benefits include hospital and ambulatory care, prescription drugs, mental health and substance‑use care, reproductive and gender‑affirming care, dental/vision/hearing, and home‑ and community‑based long‑term care.
The Secretary of HHS administers enrollment, issues a Medicare for All ID card (without Social Security numbers), and sets residency criteria and coverage rules.
To pay for the program the bill creates a Medicare for All Trust Fund and directs a mix of transfers of existing federal health dollars, annual appropriations tied to specified calculations, and revenues attributable to specified statutory changes; it also replaces many existing federal and state exchange functions. Provider payment is redesigned: institutional providers negotiate quarterly global budgets with regional directors while other clinicians are paid under an updated national fee schedule.
The bill bans private coverage that duplicates benefits and imposes new participation, reporting, and ethics rules on providers, while creating offices for equity, primary care, and a Beneficiary Ombudsman to manage transition and quality oversight.
At a Glance
What It Does
Creates a single federal health insurance program open to all U.S. residents, eliminates most patient cost‑sharing (with a narrowly tailored drug copay exception), and requires participating providers to accept program payment as payment in full. It establishes a national health budget with operating, capital, special projects, and reserve components, and a Medicare for All Trust Fund to receive redirected federal health dollars and other appropriations.
Who It Affects
All U.S. residents (automatic enrollment at birth or on establishing residency); private insurers (sale of coverage that duplicates Medicare for All is prohibited); employers (may not offer duplicate benefits and face ERISA changes); hospitals and clinics (global budgets, reporting, and ethics rules); pharmaceutical manufacturers (annual price negotiations) and States (maintenance‑of‑effort for institutional long‑term care).
Why It Matters
It is a full single‑payer redesign, not a subsidy or public option alone: it replaces many federal payers and employer duplicative coverage, centralizes benefit design and pricing, and shifts provider incentives through global budgets—meaning health plans, providers, drug manufacturers, state Medicaid systems, and employers all face large operational and financial changes.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
S.1506 rewrites who pays for health care and how it is purchased. The bill makes every U.S. resident entitled to a broad set of benefits and tasks the HHS Secretary with writing the operational rules: defining residency, enrolling people (automatic enrollment at birth or on establishing residency), issuing a non‑SSN Medicare for All card, and operating regional program offices.
The Secretary also must create uniform reporting standards, an appeals process modeled on current Medicare appeals, and an annual report to Congress on costs, access, and equity.
On benefits and patient costs the law removes routine patient cost‑sharing for covered items and services; it allows the Secretary to adopt a narrowly circumscribed prescription drug copay schedule (capped at $200 per person per year, indexed, and exempting low‑income individuals) and otherwise forbids balance billing. The benefit package is deliberately comprehensive: it explicitly includes hospital and ambulatory care, mental health and SUD treatment, contraception and abortion, gender‑affirming care, pediatrics, oral/vision/hearing services, and a set of home‑ and community‑based long‑term care services tied to existing Medicaid home‑ and community‑based rules.Providers must enroll as participating providers with a written participation agreement and meet federal and state licensing standards; the agreement imposes reporting requirements, a statutory duty of provider ethics (prohibiting financial incentives that distort care), whistleblower protections, and limits on ownership and self‑dealing.
Institutional providers obtain quarterly global budgets negotiated with regional directors and paid as lump‑sum operating payments; other clinicians are paid under an updated, annually revised national fee schedule that leverages current Medicare valuation processes. Capital projects and special infrastructure needs are funded through dedicated national health budget components managed by the Secretary and regional offices, with priority for rural, shortage, and equity areas.On financing and legal structure the bill creates a Medicare for All Trust Fund that receives transfers of current federal program dollars (including Medicare, Medicaid, and other federal health program amounts as initially calculated), plus appropriations tied to tax‑revenue changes and other statutory transfers.
It also imposes nationwide rules that prohibit private insurance or employer plans from selling coverage duplicative of program benefits once the program takes effect, while permitting supplemental coverage for benefits outside the package. During the transition window the bill establishes a Medicare Transition plan and staged buy‑in options (lowering the buy‑in age in steps) intended to provide a temporary public option while the permanent program phases in.
The bill leaves states room to add benefits or higher standards but requires a maintenance‑of‑effort for state spending on institutional long‑term care.
The Five Things You Need to Know
Start date: program benefits are scheduled to begin on January 1 of the fourth calendar year after enactment (children get earlier coverage: benefits begin January 1 of the first calendar year after enactment for those under 19, with a one‑year option to keep existing coverage).
No routine cost‑sharing: the bill bans deductibles, coinsurance, and copays for covered care, but allows an evidence‑based prescription drug copay schedule capped at $200 per person per year (indexed) with exemptions for individuals at or below 250% of the poverty line.
Provider payments split: institutional providers are paid quarterly global budgets negotiated with regional directors (payment is payment‑in‑full); individual clinicians are paid under an annually updated national fee schedule using Medicare valuation processes.
Trust Fund and funding flows: the bill creates a Medicare for All Trust Fund to receive transferred existing federal health dollars and appropriations tied to specified revenue changes; it also directs an initial transfer of amounts calculated from prior federal program spending.
Private coverage and ERISA changes: starting on the program effective date it is unlawful to sell private health insurance that duplicates Medicare for All benefits, and the bill amends ERISA to prohibit employer benefits that duplicate program coverage and repeals continuation coverage requirements in ERISA.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Establishment, universal entitlement, enrollment mechanics
This title creates the Medicare for All Program, makes every U.S. resident entitled to coverage, and directs the Secretary to write residency rules and an automatic enrollment process (including automatic enrollment at birth or upon establishing residency). It requires issuance of a Medicare for All card (without Social Security numbers) and includes a rulemaking backstop to expand eligibility in practice. The effective date structure staggers rollout: a full program start on January 1 of the fourth calendar year post‑enactment, with children covered earlier and an option to retain prior coverage during the transition.
Comprehensive benefit package and no patient cost‑sharing
The bill defines an expansive, medically necessary benefits package that explicitly includes long‑term care at home and in the community, dental/vision/hearing, reproductive and gender‑affirming care, behavioral health, and prescription drugs. It forbids patient cost‑sharing except for a narrowly defined drug copay program (evidence‑based, promotes generics, capped and income‑exempted). It mandates regular benefit reviews, a path for appeals of experimental or off‑guideline care, and allows states to add benefits but not to restrict access.
Provider participation, duties, and private contract rules
Providers must be licensed, sign participation agreements, meet federal minimum standards, comply with extensive reporting, and accept program payment as payment in full (balance billing prohibited). The participation agreement includes a new statutory duty of provider ethics (prohibiting incentives tied to utilization), disclosure rules on proprietary coding, disclosure of conflicts and ownership, and explicit whistleblower protections for staff. The bill permits limited private contracts for care not billed to the program but creates an affidavit regime, filing requirements, and penalties if providers breach those conditions.
Administration, regional offices, data, and fraud control
HHS must promulgate regulations (with public process), set uniform provider and state reporting standards, build a national database for utilization, quality and equity metrics, and publish annual implementation reports. It establishes regional Medicare for All offices with directors who negotiate budgets and assess quality and creates a Beneficiary Ombudsman to handle complaints and appeals. Fraud and abuse sanctions in current Medicare/Medicaid law extend to the program.
National health budget, global budgets, fee schedule, and cost containment
The Secretary must set an annual national health budget broken into operating, capital, special projects, quality, education, administrative, and reserve components. Institutional providers receive lump‑sum global budgets negotiated regionally and reviewed quarterly; individual clinicians and certain other providers are paid from a national fee schedule tied to current Medicare valuation mechanics. The bill creates capital and special‑project funding streams prioritized for rural, shortage, and equity areas and directs annual drug price negotiation authority.
Medicare for All Trust Fund mechanics
A statutory trust fund receives transfers and appropriations to finance program expenditures. The statute prescribes initial appropriations derived from current federal health spending (Medicare, Medicaid, FEHB, and other programs) and ongoing transfers tied to specified revenue changes and projections. The text requires periodic Treasury transfers and directs initial reconciliation mechanics—details of long‑term revenue sources and tax changes are specified in cross‑references elsewhere in the bill.
ERISA and other conforming amendments; sunsets for exchanges
ERISA is amended to prohibit employer plans that duplicate program benefits and repeals federal continuation (COBRA‑style) coverage requirements; the bill also clarifies interactions with existing federal health programs and sunsets federal/state exchanges and related statutory hooks on the program effective date. It preserves veterans', TRICARE, and Indian Health Service care but channels many federal dollars into the new trust fund and aligns state Medicaid responsibilities for institutional long‑term care.
Transition measures: Medicare improvements, buy‑in, and public option
A multi‑pronged transition is included: near‑term Medicare improvements (zeroing certain Medicare cost shares, expanding dental/vision/hearing under Medicare), a staged Medicare buy‑in (lowering the buy‑in ages incrementally), and a Medicare Transition plan—a public plan offered through Exchanges to provide coverage during the multi‑year phase‑in. The bill also includes specific protections to minimize care disruptions, consultation requirements, and a temporary worker assistance allocation for displaced administrative workers.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Uninsured and underinsured U.S. residents: The bill guarantees entitlement to a comprehensive benefit package with essentially no routine cost‑sharing, expanding financial access and eliminating gaps tied to insurance status.
- Children and families with young dependents: It accelerates coverage for those under 19 (effective in the first calendar year after enactment) and allows families to retain prior coverage for a transitional period, reducing pediatric coverage disruption.
- People needing long‑term care and home‑based services: The law explicitly covers home‑ and community‑based long‑term care services and directs states to maintain spending floors for institutional long‑term care, protecting continuity for people with chronic or severe functional needs.
- Low‑income households: The prescription drug copay carve‑out protects low‑income people (exempt at ≤250% of poverty) and the bill includes targeted capital/special project funds for medically underserved and shortage areas.
- Patients facing high annual medical bills: The combination of no routine cost‑sharing, comprehensive benefits including behavioral and dental services, and prohibitions on balance billing removes common sources of catastrophic out‑of‑pocket spending.
Who Bears the Cost
- Private health insurers and supplemental plans: Selling coverage that duplicates Medicare for All benefits becomes unlawful; insurers must shift business models toward supplemental/non‑duplicative products or exit those lines.
- Employers offering health benefits: The bill prohibits employer plans that duplicate program benefits and changes ERISA continuation rules, forcing employers to reconfigure compensation and benefits strategies.
- Federal taxpayers and beneficiaries of current federal programs: Funding is exercised through a Trust Fund that repurposes and transfers existing federal health dollars and requires new appropriations and revenue flows, meaning federal fiscal patterns and taxes will shift.
- Hospitals and health systems during the transition: Institutional providers must negotiate global budgets, invest in new reporting and operational systems, and may face revenue risk from prospective global budget caps and periodic reconciliations.
- State governments: States keep some authority but must maintain minimum spending floors on institutional long‑term care and coordinate with HHS; states also lose some roles tied to exchanges and may face short‑term administrative burdens during implementation.
Key Issues
The Core Tension
The central dilemma is straightforward but stark: guarantee universal, comprehensive, no‑cost‑sharing health coverage for all residents while keeping the program financially sustainable and preserving provider capacity and incentives. Solving one side—expanded access and richer benefits—creates pressure on budgets and provider payment systems; constraining costs through centralized budgets and price negotiation risks creating capacity, access, or innovation trade‑offs that the bill must manage through complex regional negotiation, oversight, and transitional funding.
The bill packs broad policy change into a complex administrative apparatus—and that raises multiple implementation challenges. First, financing: the Trust Fund relies on an initial reallocation of existing federal health dollars and on appropriations tied to defined formulas and revenue changes.
While the statute prescribes mechanics for transfers, actual adequacy depends on assumptions about cost growth, behavioral responses (utilization increases when care is no‑cost), and the timing of redirected funds. Absent a clearly articulated set of new revenue sources or tax rates in the bill text, the fiscal pathway to sustain comprehensive, no‑cost‑sharing benefits remains hinge‑dependent on future appropriation and legislative choices.
Second, the provider payment redesign is operationally heavy. Transitioning large numbers of hospitals and systems from fee‑for‑service to negotiated quarterly global budgets requires robust regionally based rate negotiation capacity, reliable baseline data, dispute resolution, and mechanisms to fund legitimate outlier costs (pandemics, natural disasters, market shifts).
Global budgets can control volume-driven spending but create incentives to shift costs to capital budgets or third parties unless tightly monitored. The bill imposes detailed reporting and ethics rules, but successful implementation will require substantial new administrative effort by HHS and regional offices and could strain provider cash flow during the switch.
Third, the bill alters the private insurance market and employer benefits relationship; while it prohibits duplicative products, it allows supplemental coverage. Determining the permissible boundary, preserving employer‑sponsored ancillary benefits, and enforcing prohibitions on duplicative sales present legal and regulatory complexity.
Finally, the statute balances federal uniformity with state role (states can add benefits but must preserve LTC spending floors). That split—national standards for eligibility and benefits coupled with state retention of some program administration and LTC duties—creates potential disputes over costs, data sharing, and responsibility for populations with complex needs.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.